FDA Cmte. Will Discuss Standards For Abuse-Deterrant Pain Drugs, With Focus On Embeda

Approvability of Alpharma’s abuse-resistant morphine Embeda will facilitate a broader discussion of approval standards by advisory committees Nov. 14.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet